Xunce (03317) announced that the sponsor and global coordinator, acting on its own behalf and for the international underwriters, partially exercised the over-allotment option detailed in the prospectus on Thursday, January 22, 2026. This action involved a total of 194,400 H shares, representing approximately 0.86% of the total number of shares initially available under the global offering before any over-allotment option was exercised. The over-allotment shares will be issued and allotted by the company at a price of HKD 48.00 per H share, which is the offer price per H share under the global offering, excluding the 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% FRC transaction levy, and 0.00565% SEHK trading fee.

Pursuant to Rule 9(2) of the Securities and Futures (Stabilization of Prices) Rules (Chapter 571W of the Laws of Hong Kong), the company declared that the stabilization period relating to the global offering concluded on Thursday, January 22, 2026, which is the 30th day after the deadline for submitting applications under the Hong Kong public offering. The stabilization measures undertaken by the stabilization manager, Guotai Junan Securities (Hong Kong) Limited, its affiliates, or any person acting on its behalf during the stabilization period are detailed as follows.

(i) An over-allocation of a total of 3.375 million H shares in the international offering, representing approximately 15.0% of the total number of shares initially available under the global offering before any over-allotment option was exercised.

(ii) A series of continuous purchases in the market during the stabilization period, involving a total of 3.2614 million H shares at prices ranging from HKD 38.02 to HKD 48.00 per H share (excluding the 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% FRC transaction levy, and 0.00565% SEHK trading fee). These purchases accounted for approximately 14.50% of the total number of shares initially available under the global offering before any over-allotment option was exercised. The last purchase made in the market by the stabilization manager, its affiliates, or any person acting on its behalf during the stabilization period occurred on Monday, January 12, 2026, at a price of HKD 48.00 per H share (excluding the specified fees).

(iii) A series of continuous sales in the market during the stabilization period, involving a total of 80,800 H shares at prices ranging from HKD 62.60 to HKD 72.00 per H share (excluding the 1.0% brokerage commission, 0.0027% SFC transaction levy, 0.00015% FRC transaction levy, and 0.00565% SEHK trading fee). These sales accounted for approximately 0.36% of the total number of shares initially available under the global offering before any over-allotment option was exercised. The last sale made in the market by the stabilization manager, its affiliates, or any person acting on its behalf during the stabilization period occurred on Tuesday, January 20, 2026, at a price of HKD 64.91 per H share (excluding the specified fees).

(iv) The sponsor and global coordinator, acting on its own behalf and for the international underwriters, partially exercised the over-allotment option on Thursday, January 22, 2026, at a price of HKD 48.00 per H share (the offer price per H share under the global offering, excluding the specified fees). This involved a total of 194,400 H shares, representing approximately 0.86% of the total number of shares initially available under the global offering before any over-allotment option was exercised. This action was taken to facilitate the delivery of a portion of H shares to placees who had agreed to defer the delivery of their relevant H shares subscribed under the global offering. The unexercised portion of the over-allotment option lapsed on Thursday, January 22, 2026.